Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative)

v3.21.2
NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Jul. 14, 2021
Jul. 11, 2021
Feb. 02, 2021
Jan. 19, 2021
Jun. 12, 2020
Jun. 02, 2020
Jun. 02, 2020
Apr. 15, 2020
Feb. 24, 2020
Jan. 28, 2020
Jan. 28, 2020
Jan. 31, 2021
Mar. 31, 2021
Jul. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]                                  
Reverse stock split, description               the Company effected a 1-for-10 reverse stock split (the “Reverse Split”) of its issued and outstanding common stock                  
Number of shares issued   46,029,920                              
Number of warrants exercisable   23,014,960                              
Proceeds from issuance of common stock   $ 36,259,050                              
Proceeds from issuance of common stock                             $ 77,941,089 $ 0  
Cash                             $ 31,189,160   $ 2,194,850
At The Market Offering Agreement [Member]                                  
Subsidiary, Sale of Stock [Line Items]                                  
Number of shares issued                       14,900,000   18,826,177      
Proceeds from issuance of common stock $ 40,000,000     $ 8,721,746                   $ 18,826,177      
Proceeds from issuance of common stock                       $ 16,200,000          
Proceeds from public offering net of underwriting discounts and expenses                       $ 16,242,904          
Second At The Market Offering Agreement [Member]                                  
Subsidiary, Sale of Stock [Line Items]                                  
Proceeds from issuance of common stock     $ 100,000,000                            
Proceeds from public offering net of underwriting discounts and expenses                           $ 24,602,110      
Common Stock [Member]                                  
Subsidiary, Sale of Stock [Line Items]                                  
Number of shares issued                         32,127,914        
Common Stock [Member] | At The Market Offering Agreement [Member]                                  
Subsidiary, Sale of Stock [Line Items]                                  
Number of shares issued 46,029,920                                
Proceeds from public offering net of underwriting discounts and expenses $ 36,259,050                                
Public Offering [Member]                                  
Subsidiary, Sale of Stock [Line Items]                                  
Number of shares issued         1,700,000       445,000                
Number of warrants exercisable                   2.4725 2.4725            
Proceeds from public offering net of underwriting discounts and expenses           $ 17,185,640       $ 8,549,470              
Public Offering [Member] | Common Stock [Member]                                  
Subsidiary, Sale of Stock [Line Items]                                  
Number of shares issued           19,000,000 19,000,000   445,000 4,500,000 4,500,000            
Proceeds from public offering net of underwriting discounts and expenses         $ 1,548,360       $ 839,270                
Public Offering [Member] | Warrant [Member]                                  
Subsidiary, Sale of Stock [Line Items]                                  
Number of shares issued           20,700,000 20,700,000     49.45 49,450,000